top of page

IBD Aware in the News

Advancing Care with Innovative Sweat Sensor Technology with Leading Clinicians

EnLiSense CCM, a pioneer in non-invasive, real-time inflammatory biomarker monitoring, announces the initiation of multiple groundbreaking clinical studies in collaboration with top-tier medical institutions to further the management of Chronic Diseases

Funding Surge Empowers NextGen Sensors for Breakthrough in Real-Time Biomarker Management

EnLiSense CCM Receives Funding from Crohn's & Colitis Foundation To Develop Its Real-Time Inflammation Monitor Using Sweat Sensors For Tracking And Monitoring IBD Disease Activity In Patients

Placeholder Image

Clinical Data from UChicago Supports Novel Continuous Calprotectin Monitoring Wearable for IBD Management

EnLiSense's IBD Aware device offers a pioneering solution for managing inflammatory bowel disease by continuously monitoring calprotectin levels non-invasively through innovative passive-perspiration sensor technology.

Placeholder Image

Mount Sinai and EnLiSense: Pioneering Real-Time Biomarker Monitoring through Groundbreaking Studies

EnLiSense’s device offers the first groundbreaking solution for continuous, non-invasive monitoring of inflammatory bowel disease through innovative sweat-sensing technology.

Placeholder Image

Sweat Monitoring: A New Frontier in Chronic Disease Management

Revolutionizing Inflammatory Bowel Disease Management with Cutting-Edge Wearable Technology: A Leap Towards Real-Time, Non-Invasive Monitoring and Insights Through Advanced Sweat Analysis

bottom of page